Large-scale extraction of accurate drug-disease treatment pairs from biomedical literature for drug repurposing

por Xu, Rong, Wang, QuanQiu
Publicado 2013

Large-scale combining signals from both biomedical literature and the FDA Adverse Event Reporting System (FAERS) to improve post-marketing drug safety signal detection

por Xu, Rong, Wang, QuanQiu
Publicado 2014

Comparing a knowledge-driven approach to a supervised machine learning approach in large-scale extraction of drug-side effect relationships from free-text biomedical literature

por Xu, Rong, Wang, QuanQiu
Publicado 2015

A genomics-based systems approach towards drug repositioning for rheumatoid arthritis

por Xu, Rong, Wang, QuanQiu
Publicado 2016

Towards understanding brain-gut-microbiome connections in Alzheimer’s disease

por Xu, Rong, Wang, QuanQiu
Publicado 2016

Data-driven multiple-level analysis of gut-microbiome-immune-joint interactions in rheumatoid arthritis

por Wang, QuanQiu, Xu, Rong
Publicado 2019

Immunotherapy-related adverse events (irAEs): extraction from FDA drug labels and comparative analysis

por Wang, QuanQiu, Xu, Rong
Publicado 2018

Automatic extraction, prioritization and analysis of gut microbial metabolites from biomedical literature

por Wang, QuanQiu, Xu, Rong
Publicado 2020

dRiskKB: a large-scale disease-disease risk relationship knowledge base constructed from biomedical text

por Xu, Rong, Li, Li, Wang, QuanQiu
Publicado 2014

A genome-wide systems analysis reveals strong link between colorectal cancer and trimethylamine N-oxide (TMAO), a gut microbial metabolite of dietary meat and fat

por Xu, Rong, Wang, QuanQiu, Li, Li
Publicado 2015

A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer

por Wang, QuanQiu, Li, Li, Xu, Rong
Publicado 2018

Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States

por Wang, QuanQiu, Xu, Rong, Volkow, Nora D.
Publicado 2020

When hematologic malignancies meet COVID-19 in the United States: Infections, death and disparities

por Wang, QuanQiu, Berger, Nathan A., Xu, Rong
Publicado 2021

COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States

por Wang, QuanQiu, Davis, Pamela B., Xu, Rong
Publicado 2020

Reply to “Post‐COVID 19 neurological syndrome: A new risk factor that modifies the prognosis of patients with dementia”

por Davis, Pamela B., Wang, QuanQiu, Xu, Rong
Publicado 2022

COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

por Wang, Quan Qiu, Kaelber, David C., Xu, Rong, Volkow, Nora D.
Publicado 2020

Correction: COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States

por Wang, Quan Qiu, Kaelber, David C., Xu, Rong, Volkow, Nora D.
Publicado 2020

Increased risk for COVID‐19 breakthrough infection in fully vaccinated patients with substance use disorders in the United States between December 2020 and August 2021

por Wang, Lindsey, Wang, QuanQiu, Davis, Pamela B.,  Volkow, Nora D., Xu, Rong
Publicado 2021

Gut–microbiota–microglia–brain interactions in Alzheimer’s disease: knowledge-based, multi-dimensional characterization

por Wang, QuanQiu, Davis, Pamela B., Qi, Xin, Chen, Shu G., Gurney, Mark E., Perry, George, Doraiswamy, P. Murali, Xu, Rong
Publicado 2021